Advertisement
Advertisement

TTOO

TTOO logo

T2 Biosystems Inc

0.3535
USD
+0.0133
+3.91%
Dec 18, 15:42 UTC -5
Closed
...

T2 Biosystems Inc Profile

About

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.

Info & Links

CEO

John Sperzel

Headquarters

101 HARTWELL AVENUE
LEXINGTON, MA 02421, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

13

Employees

113

T2 Biosystems Inc Statistics

Valuation Measures

Market Capitalization2

7.44M

Enterprise Value

17.28M

Enterprise Value/EBITDA(ttm)

-0.42

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.00

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-75.44%

Operating Margin(ttm)

-563.16%

Profit Margin(ttm)

-560.34%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

311.07%

Return on Assets(ttm)

-174.06%

Income Statement

Revenue(ttm)

7.68M

Revenue Per Share(ttm)

0.36

Gross Profit(ttm)

-5.89M

EBITDA(ttm)3

-41.40M

Net Income Available to Common(ttm)

-42.95M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.35

52-Week Change

-91.60%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

21.04M

Dividend Yield

0.00%

Float4

21.03M

% Held by Insiders

0.05%

% Held by Institutions

23.18%

Balance Sheet

Total Cash(mrq)

2.08M

Total Cash Per Share(mrq)

0.10

Total Debt(mrq)

11.92M

Total Debt/Equity(mrq)

-101.81%

Current Ratio(mrq)

0.40%

Quick Ratio(mrq)

0.24%

Book Value Per Share(mrq)

-0.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.52

Free Cash Flow(ytd)

-27.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement